100% is the present pregnant women living with hiv antiretroviral therapy coverage for pmtct value in Nicaragua, reflecting an increase of 9% (9.9%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Nicaragua
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Nicaragua
PMTCT antiretroviral therapy coverage
More indicators for Nicaragua
Male unintentional poisoning
0.4
0.0
(2019)
Female wasting in children
2.1%
+0.7%
(2012)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar185
+intl dollar32
(2021)
Birth registration
84.7%
+3.7%
(2012)
Contraceptive modern method prevalence
77.4%
+7.6%
(2012)
Nicaragua PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 100% | +9% |
| 2021 | 91% | +8% |
| 2020 | 83% | -17% |
| 2019 | 100% | +3% |
| 2018 | 97% | +17% |
| 2017 | 80% | -3% |
| 2016 | 83% | -8% |
| 2015 | 91% | +13% |
| 2014 | 78% | -1% |
| 2013 | 79% | -21% |
| 2012 | 100% | +11% |
| 2011 | 89% | +21% |
| 2010 | 68% | 0% |
| 2009 | 68% | +68% |
| 2008 | 0% | 0% |
| 2007 | 0% | 0% |
| 2006 | 0% | 0% |
| 2005 | 0% | -2% |
| 2004 | 2% | -2% |
| 2003 | 4% | +4% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |